Alzheimer’s Disease: Present and Future of Biomarkers for Accurate Diagnosis

Introduction

Take This Event

Join renowned experts in the field of Dementia and Alzheimer’s Disease where they will shed light on the evolving diagnostic paradigm in Alzheimer’s Disease

Objectives

• The primary objective of this meeting is to discuss the evolving diagnostic paradigm in Alzheimer's Disease.
• To focus on the clinical utility of biomarkers for the accurate diagnosis in patients with initial symptoms of AD.
• To foster an in-depth understanding of the shifting landscape in biomarker utilization to enhance timely and precise diagnoses of this neurodegenerative disease through a clinical case discussion.

Speaker

Prof. Robert Perneczky

MD, PhD | Program Moderator | DE Professor of Translational Dementia Research and Director of the Division of Mental Health in Older Adults and Alzheimer Therapy, Munich, Germany

Prof. Sylvain Lehmann

MD, PhD | Program Speaker | FR Professor at the University Hospital of Montpellier. Director, Institute of Neurosciences and the Center of Excellence in Neurodegenerative Diseases, Montpellier, France.

Dr. Pablo Martinez-Lage

MD, PhD | Program Speaker | ES Director of the Neurology area at the Center for Research and Advanced Therapies of the Foundation CITA-Alzheimer Fundazioa, San Sebastian, Spain

Provided by :